Dark

ADAP
Adaptimmune Therapeutics plc
stock NASDAQ ADR

At Close

Jun 27, 2025 3:59:30 PM EDT

0.2407USD-0.619%(-0.0015)936,666

0.2200Bid 0.2500Ask 0.0300Spread

Pre-market

Jun 27, 2025 9:06:30 AM EDT

0.2350USD-2.973%(-0.0072)26,693

After-hours

Jun 27, 2025 4:00:30 PM EDT

0.2350USD-2.368%(-0.0057)9,749

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

63.82M

Headquarters

Abingdon, Oxfordshire, United Kingdom

Industry

Biotechnology

NVAX SGMO ENZ QURE XLV

ADAP Stats

Avg. Vol. 10 Day

769,207

Avg. Vol. 30 Day

677,943

Employees

534

Market Cap

63,824,423

Shares Out.

265,051,591

On/Off Exchange

29%/71%

6 Month Beta

1.06

1 Year Beta

1.15

2 Year Beta

1.16

3 Year Beta

1.13

52 Week Low

0.20

52 Week High

1.48

SMA50

0.27

SMA200

0.55

1 Week

-4.82%

1 Month

-14.09%

3 Month

+9.46%

6 Month

-59.19%

1 Year

-75.45%

2 Year

-73.33%

5 Year

-97.46%

Profile

adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.

ADAP Stock Summary

Adaptimmune Therapeutics plc (NASDAQ:ADAP) stock price today is $0.2407, and today's volume is 936,666. ADAP is down -0.619% today. The 30 day average volume is 677,943. ADAP market cap is 63.82M with 265,051,591 shares outstanding.